Cabot (CBT) FY2025 results: revenue $3.7 billion, down 7.0% on the year
Cabot Corp. (CBT) reported revenue of $3.7 billion for fiscal 2025, the year ended 30 September 2025, down 7.0% on the year before. Net income was $331 million, down 12.9%, and diluted earnings per share $6.02. The figures are the company's own, from the 10-K it filed with the SEC on 24 November 2025.
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Guidance figures: 2 new.
- Fiscal 2025 Adjusted EPS rose 3%: Adjusted EPS for fiscal 2025 was $7.25, against $7.06 a year earlier. Diluted EPS was $6.02, against $6.72. Net sales were $3,713 million, against $3,994 million.
- Fourth quarter Adjusted EPS fell 6%: Fourth quarter Adjusted EPS was $1.70, against $1.80 a year earlier. Diluted EPS was $0.79, against $2.43. Net sales were $899 million, against $1,001 million.
- Segment EBIT moved in opposite directions: Reinforcement Materials EBIT fell 5% for the year while Performance Chemicals EBIT rose 18%. Total segment EBIT was $702 million, against $701 million.
- Americas volumes fell on tire imports: Americas volumes fell as tire customers cut production amid higher tire imports from Asia. Asia Pacific volumes also declined. Fourth quarter EBIT fell $4 million, partly offset by cost management.
- Fourth quarter EBIT fell on volume: Performance Chemicals fourth quarter EBIT fell $2 million, mainly on a 5% volume decrease, partly offset by lower costs.
From this 10-K
Cabot is a specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Its principal products are reinforcing and specialty carbons, specialty compounds, conductive additives, carbon nanotubes, fumed metal oxides, inkjet colorants and aerogel. The business was founded in 1882 and incorporated in Delaware in 1960, and it has manufacturing facilities in the United States and over 20 other countries. It reports two segments, Reinforcement Materials and Performance Chemicals.
The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025
Income statement (profit and loss)
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Revenue | 3,713 | 3,994 | 3,931 | -7.0% | |
| Cost of revenue | 2,773 | 3,034 | 3,092 | -8.6% | |
| Gross profit | 940 | 960 | 839 | -2.1% | |
| Gross margin | 25.3% | 24.0% | 21.3% | ||
| Research and development | 59.0 | 63.0 | 57.0 | -6.3% | |
| Selling, general and administrative | 260 | 283 | 253 | -8.1% | |
| Operating income | 621 | 614 | 526 | +1.1% | |
| Operating margin | 16.7% | 15.4% | 13.4% | ||
| Interest expense | 76.0 | 81.0 | 90.0 | -6.2% | |
| Pre-tax income | 565 | 529 | 451 | +6.8% | |
| Income tax | 196 | 111 | -28.0 | +76.6% | |
| Effective tax rate | 34.7% | 21.0% | -6.2% | ||
| Net income | 331 | 380 | 445 | -12.9% | |
| Net margin | 8.9% | 9.5% | 11.3% | ||
| Diluted EPS | $6.02 | $6.72 | $7.73 | -10.4% |
Read more
Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.Cash flow
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Operating cash flow | 665 | 692 | 595 | -3.9% | |
| Capital expenditure | 274 | 241 | 244 | +13.7% | |
| Free cash flow | 391 | 451 | 351 | -13.3% | |
| Free cash flow margin | 10.5% | 11.3% | 8.9% | ||
| Cash from investing | -298 | -235 | -214 | ||
| Cash from financing | -336 | -415 | -403 | ||
| Depreciation and amortisation | 154 | 151 | 144 | +2.0% | |
| Share-based compensation | 24.0 | 25.0 | 20.0 | -4.0% | |
| Buybacks | 168 | 172 | 98.0 | -2.3% | |
| Dividends paid | 96.0 | 93.0 | 88.0 | +3.2% | |
| Dividend per share | $1.76 | $1.66 | $1.54 | +6.0% | |
| Diluted shares, weighted | 54m | 56m | 56m | -2.7% | |
| Shares outstanding at period end | 53m | 54m | 55m | -2.7% |
Balance sheet
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Shareholders' equity | 1,550 | 1,425 | 1,264 | +8.8% | |
| Non-controlling interest | 155 | 165 | 143 | -6.1% | |
| Debt | 1,130 | 1,140 | 1,276 | -0.9% | |
| Operating lease liabilities | 85.0 | 88.0 | 84.0 | -3.4% | |
| Finance lease liabilities | 24.0 | 23.0 | 24.0 | +4.3% | |
| Other liabilities | 871 | 895 | 813 | -2.7% | |
| Total liabilities and equity | 3,815 | 3,736 | 3,604 | +2.1% | |
| Fixed assets | 1,711 | 1,534 | 1,412 | +11.5% | |
| Goodwill | 134 | 133 | 134 | +0.8% | |
| Intangible assets | 55.0 | 53.0 | 60.0 | +3.8% | |
| Cash and equivalents | 258 | 223 | 238 | +15.7% | |
| Inventory | 504 | 552 | 585 | -8.7% | |
| Other assets | 1,153 | 1,241 | 1,175 | -7.1% | |
| Total assets | 3,815 | 3,736 | 3,604 | +2.1% |
10-K for the year ended 30 September 2025, filed 24 November 2025: the filing.